Thank you for your interest in the PHYOXTM Clinical Trials!
A study representative will be in touch with you shortly.
A study representative will be in touch with you shortly.
Nedosiran, formerly DCR-PHXC, is an investigational drug intended for the treatment of patients with PH. Investigational drugs are medicines that have not yet been approved by appropriate regulatory agencies. The safety and efficacy for nedosiran has not been established yet. Current and future studies are evaluating the safety and efficacy for nedosiran.
©2021 Dicerna Pharmaceuticals, Inc. / Lexington, MA
MED-ALL—000011 v2.0